A549 cells infected with RSV Analysis Results (GEO series: GSE147507)
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr5_-_179780312 Show fit | 1.10 |
ENST00000253778.8
|
glutamine-fructose-6-phosphate transaminase 2 |
|
chr15_+_41221536 Show fit | 1.03 |
ENST00000249749.5
|
delta-like 4 (Drosophila) |
|
chr16_+_1031762 Show fit | 0.85 |
ENST00000293894.3
|
SRY (sex determining region Y)-box 8 |
|
chr6_+_19837592 Show fit | 0.79 |
ENST00000378700.3
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein |
|
chr2_+_155554797 Show fit | 0.74 |
ENST00000295101.2
|
potassium inwardly-rectifying channel, subfamily J, member 3 |
|
chr5_+_52285144 Show fit | 0.70 |
ENST00000296585.5
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) |
|
chr4_-_177713788 Show fit | 0.69 |
ENST00000280193.2
|
vascular endothelial growth factor C |
|
chr6_+_126112001 Show fit | 0.62 |
ENST00000392477.2
|
nuclear receptor coactivator 7 |
|
chr1_+_40420802 Show fit | 0.61 |
ENST00000372811.5
ENST00000420632.2 ENST00000434861.1 ENST00000372809.5 |
major facilitator superfamily domain containing 2A |
|
chr19_+_51815102 Show fit | 0.59 |
ENST00000270642.8
|
IgLON family member 5 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.0 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.3 | 0.9 | GO:0072034 | renal vesicle induction(GO:0072034) |
0.1 | 0.9 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.2 | 0.8 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.2 | 0.7 | GO:0033341 | regulation of collagen binding(GO:0033341) |
0.1 | 0.7 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
0.1 | 0.7 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.0 | 0.7 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
0.1 | 0.6 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.0 | 0.6 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.5 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 0.7 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.0 | 0.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 0.5 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.0 | 0.5 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 0.4 | GO:0018444 | translation release factor complex(GO:0018444) |
0.1 | 0.4 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 0.4 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.1 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 1.5 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 1.0 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.9 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.8 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.7 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.1 | 0.7 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.0 | 0.7 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.0 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.9 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.7 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 0.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.6 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.6 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.6 | PID ERBB4 PATHWAY | ErbB4 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.1 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 1.1 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 1.0 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.9 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 0.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.7 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.7 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.6 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |